Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 34 | 159 | 224 | 142 | 25,305 |
| Cost of Goods | 12 | 64 | 85 | 54 | 2,038 |
| Gross Profit | 22 | 95 | 139 | 88 | 23,267 |
| Operating Expenses | 12,495 | 26,403 | 24,187 | 28,551 | 27,658 |
| Operating Income | -12,461 | -26,244 | -23,963 | -28,409 | -4,353 |
| Other Income | 691 | 5,287 | -3,381 | -121 | 16,979 |
| Pre-tax Income | -11,770 | -20,957 | -27,344 | -28,530 | 12,626 |
| Income Tax | N/A | 1 | 10 | N/A | 324 |
| Net Income Continuous | -11,770 | -20,958 | -27,354 | -28,530 | 12,302 |
| Net Income | $-11,770 | $-20,958 | $-27,354 | $-28,530 | $12,302 |
| EPS Basic Total Ops | -0.26 | -0.45 | -0.57 | -0.60 | 0.25 |
| EPS Basic Continuous Ops | -0.25 | -0.44 | -0.58 | -0.60 | 0.25 |
| EPS Diluted Total Ops | -0.26 | -0.45 | -0.57 | -0.60 | 0.25 |
| EPS Diluted Continuous Ops | -0.25 | -0.44 | -0.58 | -0.60 | 0.25 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.45 | -0.54 | -0.60 | 0.27 |
| EBITDA(a) | $-12,348 | $-26,088 | $-23,815 | $-28,271 | $-4,213 |